Multiple Myeloma Turkish Prospective Patient Registry

Multiple Myeloma Patient Registry - Prospective National Multi Center Prospective Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04143932

Acronym

THD-MM-Reg

Enrollment

1000

Registered

2019-10-30

Start date

2020-10-10

Completion date

2024-12-31

Last updated

2023-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Myeloma, Relapse Multiple Myeloma

Keywords

multiple myeloma, MM, Registry, Turkey

Brief summary

This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey

Detailed description

In this study, approximately from 40 centers 1000 patients will be recruited. All patients will be followed-up till the study end. All the laboratory results, treatment protocols and responses will be recorded and assessed with EORTC Multiple Myeloma Specific Quality of Life Multiple Myeloma Specific (MY-20) and EORTC Quality of Life-C30 questionnaires.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosed as multiple myeloma * Patients signed informed consent form * Patients received no more then 2 lines of therapy

Exclusion criteria

* Patients below 18 years old

Design outcomes

Primary

Measure	Time frame	Description
Overall Survival	[Time Frame: 5 Years]	Time from the diagnosis to the death
Progression Free Survival	[Time Frame: 5 Years]	Time from the initiation of treatment to the death from any cause or progression

Countries

Turkey (Türkiye)

Contacts

Primary ContactOmur Gokmen Sevindik, Assoc. Prof.

omurgok17@hotmail.com+905427870708

Backup ContactIlker Kurkcu, Pharm

ilker.kurkcu@sentez-cro.com+905326354515

Outcome results